Profound Medical (TSE:PRN) has released an update.
Profound Medical Corp. is set to update investors on its business strategies and advancements at the Bloom Burton & Co. Healthcare Investor Conference, showcasing its incision-free medical devices such as TULSA-PRO for prostate ablation and Sonalleve for treating uterine fibroids and bone metastases. The Company’s presentation will be streamed live from the Metro Toronto Convention Centre on April 16, 2024. Profound Medical’s technologies, which are approved in various regions, aim to improve patient outcomes through customizable, non-invasive treatments.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
